Emerillon Capital and Sanderling Ventures Join Forces Backing a New Precision Medicine Company Based in Montreal, Canada
Montreal – May. 10th, 2017 – Emerillon Capital and Sanderling Ventures announced they are joining forces to finance PreciThera Inc, an emerging Montreal based precision medicine company dedicated to the design and the development of innovative biological agents for the treatment of orphan diseases. PreciThera was….
Therillia Names Dr. Pierre Beauparlant Chief Business Officer
Montreal – Dec. 5th, 2016 – Therillia Development Company Inc., a Sanderling Ventures portfolio company, announced today the appointment of Dr. Pierre Beauparlant as Chief Business Officer. He will be responsible for the development and execution of…